Inhibitory Effects of Gymnema (<i>Gymnema sylvestre</i>) Leaves on Tumour Promotion in Two-Stage Mouse Skin Carcinogenesis

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left" rowspan="2">Component</td><td align="center">ID50</td><td align="center">95% CI</td></tr><tr class="thead"><td align="center" colspan="2">
								(nmol/ear)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">Gymnemagenin (<b>2</b>)</td><td align="center">555</td><td align="center">417–739</td></tr><tr><td align="left">28-Acetyl-21-tigloylgymnemagenin (<b>3</b>)</td><td align="center">49.7</td><td align="center">38.3–64.7</td></tr><tr><td align="left">Gymnemic acid III (<b>4</b>)</td><td align="center">212</td><td align="center">160–281</td></tr><tr><td align="left" colspan="3"><hr/></td></tr><tr><td align="left">Indomethacin<sup>a</sup></td><td align="center">908</td><td align="center">755–1092</td></tr><tr><td align="left">Hydrocortisone<sup>a</sup></td><td align="center">69.1</td><td align="center">64.3–75.4</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>ID<sub>50</sub>: 50% inhibitory dose. 95% CI: 95% confidence intervals. <sup>a</sup>Reference compound.<br/></td></tr></table>

Inhibitory effects of components from gymnema leaves on TPA-induced inflammatory ear oedema.

Evidence-Based Complementary and Alternative Medicine

tab2

Table 2

Table 2: Inhibitory Effects of Gymnema (<i>Gymnema sylvestre</i>) Leaves on Tumour Promotion in Two-Stage Mouse Skin Carcinogenesis 

Evidence-Based Complementary and Alternative Medicine

Inhibitory Effects of Gymnema (Gymnema sylvestre) Leaves on Tumour Promotion in Two-Stage Mouse Skin Carcinogenesis

Table 2